Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00111774 | Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma | completed | Phase 2 | 150 | AmgenINDUSTRY | 0 | May 14, 2013 | clinicaltrials |
| NCT00290615 | Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 30 | Herbert HurwitzOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | terminated | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01839539 | Study of DC-CIK to Treat Colorectal Cancer | unknown | Phase 2 | 60 | Guangxi Medical UniversityOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT01832948 | Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT00004193 | ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer | terminated | Phase 2 | 25 | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00005076 | Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | 110 | University of Alabama at BirminghamOTHER | 0 | Apr 12, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01329809 | Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors | terminated | Phase 2 | 2 | Jennerex BiotherapeuticsINDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00258232 | Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00405561 | Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003 | terminated | Phase 2 / Phase 3 | 67 | Auron Healthcare GmbHINDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00086931 | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 37 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | completed | Phase 2 | 24 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00004870 | Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 1 / Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | completed | Phase 2 | 136 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00531115 | Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer. | terminated | Phase 2 | 28 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00681876 | Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer | terminated | Phase 2 | 16 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00755534 | Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC | terminated | Phase 2 | 68 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00005085 | Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003995 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2013 | clinicaltrials |
| NCT00002796 | Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | terminated | Phase 1 / Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00087334 | Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 1 / Phase 2 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00005864 | Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00444041 | Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer(ASSO-LM1) | completed | Phase 1 / Phase 2 | 43 | Austrian Society Of Surgical OncologyOTHER | 1 | Jan 30, 2013 | clinicaltrials |
| NCT01763450 | Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00070265 | Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer | terminated | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005818 | SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00041340 | Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00378066 | Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer | completed | Phase 2 | 49 | Asan Medical CenterOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01619696 | Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas | terminated | Phase 2 | 3 | University Hospital, ToulouseOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00052585 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00077259 | Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01116271 | Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec | completed | Phase 2 | 32 | AstraZenecaINDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00039273 | Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 44 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00784446 | First-line Therapy of Stage IV Colorectal Cancer | completed | Phase 1 / Phase 2 | 51 | University of CologneOTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00049335 | S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed | completed | Phase 2 | 29 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00118105 | S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00766220 | Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jan 3, 2013 | clinicaltrials |
| NCT00597506 | Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus(BEV/EV) | completed | Phase 2 | 50 | Herbert HurwitzOTHER | 1 | Dec 27, 2012 | clinicaltrials |
| NCT00466505 | Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 17 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00557102 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung(ERBIFORT) | completed | Phase 2 | 24 | National Cancer Institute, FranceOTHER_GOV | 1 | Dec 11, 2012 | clinicaltrials |
| NCT01320319 | Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients(EPA-colo) | unknown | Phase 2 / Phase 3 | 70 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
Data updated 23 days agoSource updated May 15, 2013source: clinicaltrials